{"result": {"id": "050232f4-4628-4133-9f30-1dadfcd93548", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>NICARDIPINE<|>ORGANIZATION<|>Nicardipine is a calcium channel blocker used as intravenous medication for blood pressure control in ICH patients\")  \n##\n(\"entity\"<|>URAPIDIL<|>ORGANIZATION<|>Urapidil is an antihypertensive drug used for acute blood pressure management in cerebral hemorrhage cases\")  \n##\n(\"entity\"<|>NITROGLYCERIN<|>ORGANIZATION<|>Nitroglycerin is a vasodilator medication sometimes used in emergency hypertension treatment\")  \n##\n(\"entity\"<|>MANNITOL<|>ORGANIZATION<|>Mannitol is an osmotic diuretic used to reduce intracranial pressure in ICH patients\")  \n##\n(\"entity\"<|>GLYCEROL FRUCTOSE<|>ORGANIZATION<|>Glycerol fructose is a hypertonic solution used to manage cerebral edema\")  \n##\n(\"entity\"<|>PROPOFOL<|>ORGANIZATION<|>Propofol is a sedative agent used for intracranial pressure management in ICH\")  \n##\n(\"entity\"<|>ETOMIDATE<|>ORGANIZATION<|>Etomidate is an intravenous anesthetic used for sedation in neurocritical care\")  \n##\n(\"entity\"<|>MIDAZOLAM<|>ORGANIZATION<|>Midazolam is a benzodiazepine sedative used in ICH patient management\")  \n##\n(\"entity\"<|>MORPHINE<|>ORGANIZATION<|>Morphine is an opioid analgesic used for pain control in neurocritical cases\")  \n##\n(\"entity\"<|>ALFENTANIL<|>ORGANIZATION<|>Alfentanil is a short-acting opioid used for analgesia in ICH patients\")  \n##\n(\"relationship\"<|>NICARDIPINE<|>ICH<|>Nicardipine is a first-line intravenous antihypertensive for acute ICH management<|>8)  \n##\n(\"relationship\"<|>URAPIDIL<|>ICH<|>Urapidil is an alternative intravenous antihypertensive for ICH patients<|>7)  \n##\n(\"relationship\"<|>NITROGLYCERIN<|>ICH<|>Nitroglycerin may be used for emergency blood pressure control in ICH<|>6)  \n##\n(\"relationship\"<|>MANNITOL<|>ICH<|>Mannitol is a primary osmotic agent for reducing intracranial pressure in ICH<|>9)  \n##\n(\"relationship\"<|>GLYCEROL FRUCTOSE<|>ICH<|>Glycerol fructose is an alternative hyperosmolar therapy for cerebral edema in ICH<|>7)  \n##\n(\"relationship\"<|>PROPOFOL<|>ICH<|>Propofol is used for sedation to prevent ICP elevation in ICH patients<|>8)  \n##\n(\"relationship\"<|>ETOMIDATE<|>ICH<|>Etomidate provides hemodynamically stable sedation for ICH procedures<|>7)  \n##\n(\"relationship\"<|>MIDAZOLAM<|>ICH<|>Midazolam is used for sedation in ventilated ICH patients<|>7)  \n##\n(\"relationship\"<|>MORPHINE<|>ICH<|>Morphine provides analgesia while minimizing ICP elevation in ICH<|>7)  \n##\n(\"relationship\"<|>ALFENTANIL<|>ICH<|>Alfentanil offers short-duration analgesia for ICH procedures<|>6)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752165613, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 795, "prompt_tokens": 2895, "total_tokens": 3690, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2560}, "prompt_cache_hit_tokens": 2560, "prompt_cache_miss_tokens": 335}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 疾病\n\n五、治疗\n（一）内科治疗\n\n6\n\n\n　　　I CH患者在发病的最初数天内病情往往不稳定， 应常规持 续生命体征监测（包括血压监测、心电监测、氧饱和度监测） 和定时神经系统评估， 密切观察病情及血肿变化， 定时复查头 部CT，尤其是发病3小时内行首次头部CT患者，应于发病后8小 时、最迟24小时内再次复查头部CT。\n　　　ICH的治疗的首要原则是保持安静，稳定血压，防止继续出 血；根据情况，适当降低颅内压，防治脑水肿，维持水电解质、 血糖、体温平衡； 同时加强呼吸道管理及护理，预防及防止各种 颅内及全身并发症[6]。\n　　　1. 控制血压： 急性脑出血患者常伴有明显血压升高， 且血 压升高的幅度通常超过缺血性脑卒中患者，这增加了I CH患者残 疾、死亡等风险。急性脑出血抗高血压研究（AT ACH）和急性 脑出血积极降压治疗研究（INTERACT、INTERACT-2）三个 研究[19-21]为I CH患者早期降压提供了重要依据。研究显示将收缩 压控制在140mmHg以下可以降低血肿扩大的发生率而不增加不 良反应事件，但对3个月的病死率和致残率没有明显改善。脑出 血早期以及血肿清除术后应立即使用药物迅速控制血压，但也要 避免长期严重高血压患者血压下降过快、过低可能产生的脑血流 量下降。如因CUSHING’反应或中枢性原因引起的异常血压升 高，则要针对病因进行治疗，不宜单纯盲目降压。\n1.1 常用静脉降压药物：尼卡地平，乌拉地尔，硝酸甘油等；\n　　　1.2 常用口服降压药物：长效钙通道阻滞剂，血管紧张素Ⅱ 受体阻滞剂，β1肾上腺素能受体阻滞剂等；\n2. 降低颅内压，控制脑水肿：\n　　　2.1 抬高床头约30°, 头位于中线上，以增加颈静脉回流， 降低颅内压。\n　　　2.2 对需要气管插管或其他类似操作的患者，需要静脉应用 镇静剂。镇静剂应逐渐加量，尽可能减少疼痛或躁动引起颅内压 升高。常用的镇静药物有：二异丙酚、依托咪酯、咪达唑仑等；\n\n7\n\n\n镇痛药有：吗啡、阿芬太尼等。\n　　　2,3 药物治疗： 若患者具有颅内压增高的临床或影像学表 现， 和/或实测I CP>20mmHg， 可应用脱水剂， 如20%甘露醇 （1-3g/Kg/天）、甘油果糖、高渗盐水、白蛋白、利尿剂等)，\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>ICH<|>EVENT<|>Intracerebral Hemorrhage (ICH) is a type of stroke caused by bleeding within the brain tissue, requiring immediate medical attention and monitoring\")\n##\n(\"entity\"<|>ATACH<|>EVENT<|>Acute Brain Hemorrhage Antihypertensive Treatment Study (ATACH) is a research study providing evidence for early blood pressure control in ICH patients\")\n##\n(\"entity\"<|>INTERACT<|>EVENT<|>Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT) is a study investigating the effects of aggressive blood pressure lowering in ICH patients\")\n##\n(\"entity\"<|>INTERACT-2<|>EVENT<|>Follow-up study to INTERACT, further examining blood pressure management in acute ICH cases\")\n##\n(\"entity\"<|>CUSHING’S RESPONSE<|>EVENT<|>A physiological response to increased intracranial pressure, causing abnormal blood pressure elevation\")\n##\n(\"relationship\"<|>ICH<|>ATACH<|>ATACH study provides clinical guidelines for blood pressure management in ICH cases<|>7)\n##\n(\"relationship\"<|>ICH<|>INTERACT<|>INTERACT study established protocols for aggressive blood pressure control in ICH<|>7)\n##\n(\"relationship\"<|>ICH<|>INTERACT-2<|>INTERACT-2 study further refined blood pressure management approaches for ICH<|>7)\n##\n(\"relationship\"<|>ICH<|>CUSHING’S RESPONSE<|>Cushing's response may occur as a complication of severe ICH<|>5)\n##\n(\"relationship\"<|>ATACH<|>INTERACT<|>Both studies investigate blood pressure control in acute ICH but with different protocols<|>6)\n##\n(\"relationship\"<|>INTERACT<|>INTERACT-2<|>INTERACT-2 is the follow-up study to INTERACT with expanded research parameters<|>8)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_a24d0caedf3436c12fc8e3a7484a77de778f28a9ecb74786f0f702ea0d8afda2_v2"}